Surgical Intervention for Skin Cancer in Organ Transplant Recipients
An important complication of solid organ transplantation and chemical immunosuppression is the potential for the development of multiple skin cancers, especially squamous cell carcinomas . The magnitude and severity of these malignancies are troublesome. They are often multiple, are associated with verrucal lesions, are more likely to occur at a younger age, and have a higher recurrence rate than in those who do not receive transplants, are capable of rapid growth, have an aggressive histological growth pattern [2,3], and are prone to metastasis on the trunk and extremities as well as the head and neck.
KeywordsSquamous Cell Carcinoma Transplant Recipient Sentinel Lymph Node Biopsy Skin Cancer Basal Cell Carcinoma
Unable to display preview. Download preview PDF.
- 6.Shelley WB, Shelley ED. Advanced dermatologic therapy. Philadelphia: Saunders, 1987.Google Scholar
- 9.Stasko T, Brown MD, Carucci JA, Euvrard S, Johnson TM, Sengelmann RD, et al.; International Transplant-Skin Cancer Collaborative; European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004; 30(4 pt 2):642–50.PubMedCrossRefGoogle Scholar
- 13.Carucci JA, Martinez JC, Zeitouni NC, Christenson L, Coldiron B, Zweibel S, et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004; 30 (4 pt 2):651–5.PubMedCrossRefGoogle Scholar